Investing With Your Brain's Heart

Frontlines | Investing With Your Brain's Heart Anne MacNamara When it comes to money, smart people act reasonably instead of emotionally to make good decisions, right? Not according to research conducted by an international team of neurologists, economists, and psychologists (J. Dickhaut et al., "The impact of the certainty context on the process of choice," Proc Natl Acad Sci, 100:3536-41, March 18, 2003). The results, based on brain scans of people making economic decisions, show that emo

Written bySam Jaffe
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

When it comes to money, smart people act reasonably instead of emotionally to make good decisions, right? Not according to research conducted by an international team of neurologists, economists, and psychologists (J. Dickhaut et al., "The impact of the certainty context on the process of choice," Proc Natl Acad Sci, 100:3536-41, March 18, 2003). The results, based on brain scans of people making economic decisions, show that emotions rule the domain of financial decision-making.

Test subjects were asked to choose between taking a 50/50 chance to get $200 or a 100% chance to get $100; most chose the guaranteed C-note. Surprisingly, though, while the subjects made this apparently clear-headed decision, the ventromedial cortex, which regulates emotions, increased in activity. However, when given a second choice between definitely keeping $100 or taking an undefined risk of losing it all in order to maybe gain more money, brain activity shifted to the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies